Here is Why H.C. Wainwright Sees Immense Upside for Viking Therapeutics (VKTX)

On December 18, H.C. Wainwright expert Joseph Pantginis reaffirmed his Buy standing connected Viking Therapeutics (NASDAQ:VKTX). The expert has forecasted a immense upside imaginable of astir 190% from the prevailing range, with a terms people of $102 a share.

oatautta/Shutterstock.com

Pantginis maintains a semipermanent presumption based connected the company’s differentiated VK2735 oral and injectable formulations. This presumption comes aft immoderate affirmative outcomes of the Phase 3 ATTAIN-MAINTAIN study, based connected the aforesaid molecule, conducted by their rival Eli Lilly. The results bespeak that the oral therapies are arsenic effectual successful preserving the value loss, which antecedently was associated with injections. This would facilitate a highly creaseless modulation from injections to oral therapies for chronic treatments, without overmuch risk.

These results from Eli Lilly’s survey validate the ongoing efforts connected Viking’s oral obesity program. Apart from curtailing the commercialized risks associated with the program, they volition besides summation capitalist involvement successful the company.

Consensus estimates arsenic of December 19 besides bespeak much than 176% upside imaginable for Viking Therapeutics (NASDAQ:VKTX). The forecasted people terms for the banal is $97.27, with each 13 analysts assigning Buy ratings.

Viking Therapeutics (NASDAQ:VKTX) specializes successful therapies for metabolic and endocrine disorders. As a clinical-stage biopharmaceutical company, they nonstop their probe efforts towards small-molecule drugs to cure obesity, fatty liver, and diabetes.

While we admit the imaginable of VKTX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT:  Cathie Wood’s Stock Portfolio: Top 10 Stocks to Buy and 30 Most Fantastic Stocks Every Investor Should Pay Attention To.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.